Vaxcyte, Inc. — Director's Dealing 2023

Jan 4, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2023-01-01

Reporting Person: Cowan Elvia (See Remarks Section)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$25.92	2032-08-08	Common Stock (140000)		Direct
Stock Option (Right to Buy)	$47.95	2032-12-30	Common Stock (15000)		Direct

Footnotes

F1: 1/4 of the shares subject to the option shall vest on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.

F2: 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.